Opiant Pharmaceuticals, Inc.
Save
108.80M
Market cap
Current P/E
26.74x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders.

Similar securities

Based on sector and market capitalization

Report issue